Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Elixxer Ltd. V.QBA


Primary Symbol: V.ELXR

Elixxer Ltd is a Canada based company engaged in growing and producing medical-grade cannabis. It focuses on making investments in Nutraceuticals, Cosmetics, Pharma, and Cultivation and Extraction sectors.


TSXV:ELXR - Post by User

Post by keeniinvestoron Sep 19, 2018 8:11pm
192 Views
Post# 28651746

NEWS just in ....

NEWS just in ....

TSX final approval must be imminent ......

LGC Capital subscription of Global Canna debenture

LGC Capital Ltd (C:LG) 
Shares Issued 374,714,485
Last Close 9/19/2018 $0.185
Wednesday September 19 2018 - Miscellaneous

The TSX Venture Exchange has accepted for filing the documentation relating to an arm's-length subscription of a $2.5-million secured convertible debenture of Global Canna Labs Ltd. (GCL), with an annual interest rate of 7 per cent, convertible into a 30-per-cent interest in GCL. In addition, the company acquired a 5-per-cent royalty on GCL's net sales for a consideration of 15,854,141 common shares of the company.

The company paid a finder's fee of $128,750 in cash and 1,020,610 in common shares of the company in connection with the transaction.

For further information, please refer to the company's press releases dated Jan. 26, 2018, and Aug. 30, 2018.

<< Previous
Bullboard Posts
Next >>